首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1654633

全球女性科技市場 - 2025 年至 2033 年

Global Femtech Market - 2025-2033

出版日期: 2025年02月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球女性科技市場規模達到 389 億美元，預計到 2033 年將達到 1,123 億美元，2025-2033 年預測期內的複合年成長率為 12.6%。

女性科技是醫療保健領域的一個變革性領域，專注於透過創新解決方案滿足女性獨特的健康需求。它涵蓋各種產品和服務，包括診斷工具、穿戴式裝置、遠距醫療平台和行動應用程式，專門針對女性特定的狀況，如產婦健康、月經健康、骨盆和性健康、生育能力、更年期和避孕。

此外，女性科技也解決對女性影響特別嚴重的一般健康問題，例如骨質疏鬆症和心血管疾病。

市場動態：

促進因素與約束因素

不斷進步的技術

不斷進步的技術正在極大地推動女性科技市場的發展。穿戴式健康追蹤器、生育監測器和月經健康設備等新型尖端產品的頻繁推出，進一步推動了市場擴張。這些進步不僅提高了女性科技解決方案的準確性和功能性，而且還增加了消費者的信任和採用，促進了市場的持續成長。例如，2023 年 12 月，Arva Health 推出了針對女性的家庭生育測試。這項測試可幫助女性監測和追蹤她們的荷爾蒙，使她們能夠對生殖健康做出明智的選擇。

科技公司、醫療保健提供者和新創公司之間的合作正在加速創新，並推動開發更先進、更方便用戶使用的適合女性健康的設備。例如，2024 年 10 月，拜耳與精準護理領域的創新深度科技新創公司 Impli 建立了合作關係。此次合作旨在推動早期研究，同時探索荷爾蒙監測的各種潛在用例，並為 Impli 提供拜耳全球創新生態系統的使用權。因此，預計上述因素將推動市場成長。

生產成本高

預計先進女性科技設備的高成本將限制大量潛在消費者的取得能力，從而阻礙女性科技市場的發展。由於許多女性科技解決方案（尤其是穿戴式裝置和專門的健康設備）價格昂貴，因此並非所有用戶都能負擔得起，尤其是在新興市場或低收入者中。這種價格障礙可能會降低採用率，因為消費者可能會猶豫是否要投資這些沒有明顯、直接利益的產品。此外，高昂的成本可能會限制醫療保健提供者和保險公司廣泛提供這些解決方案的能力，從而進一步限制市場成長。

HeraMED
Flo Health Inc.
Allara Health
Bloomlife
Syrona Health
Joylux, Inc.
Coroflo Ltd.
Bonzun
Natural Cycles USA Corp
Similar data will be provided for each market player.
雅典娜女性科技公司
- 管道產品描述
- 產品關鍵績效指標 (KPI)
- 主要活動
- 市場進入時間表
- 產品滲透率
- 銷售估計和預測
赫博紐特拉
蘭花生命科學
印度世界
Aushadhi 草藥
將為每個市場參與者提供類似的資料。

第 12 章：附錄

簡介目錄

Product Code: PH9084

The global femtech market reached US$ 38.90 billion in 2024 and is expected to reach US$ 112.30 billion by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033.

FemTech is a transformative sector within healthcare that focuses on addressing women's unique health needs through innovative solutions. It encompasses various products and services, including diagnostic tools, wearables, telemedicine platforms, and mobile applications that cater specifically to female-specific conditions such as maternal health, menstrual health, pelvic and sexual health, fertility, menopause, and contraception.

Moreover, FemTech also addresses general health issues that disproportionately affect women, such as osteoporosis and cardiovascular diseases.

Market Dynamics: Drivers & Restraints

Rising Technological Advancements

Rising technological advancements are significantly driving the femtech market. The frequent launch of new, cutting-edge products, such as wearable health trackers, fertility monitors, and menstrual health devices, is further fueling market expansion. These advancements not only improve the accuracy and functionality of femtech solutions but also increase consumer trust and adoption, contributing to the continued growth of the market. For instance, in December 2023, Arva Health launched home fertility tests for women. This test helps women monitor and track their hormones, thus empowering them to make informed choices about their reproductive health.

Collaborations between tech companies, healthcare providers, and startups are accelerating innovation and enabling the development of more advanced, user-friendly devices tailored to women's health. For instance, in October 2024, Bayer entered into a partnership with Impli, an innovative, deep-tech start-up in precision care. The partnership is intended to advance early-stage research while exploring a variety of potential use cases for hormone monitoring and providing Impli with access to Bayer's global innovation ecosystem. Thus, the above factors are expected to drive the market growth.

High production costs

High costs associated with advanced femtech devices are expected to hinder the femtech market by limiting accessibility for a large segment of potential consumers. As many femtech solutions, particularly wearables and specialized health devices can be expensive, they may not be affordable for all users, especially in emerging markets or among lower-income populations. This price barrier can slow down adoption rates, as consumers may be hesitant to invest in these products without clear, immediate benefits. Additionally, the high costs may limit the ability of healthcare providers and insurers to offer these solutions widely, further restricting the market growth.

Segment Analysis

The global femtech market is segmented based on type, application, end-user, and region.

Type:

Devices segment is expected to dominate the global femtech market share

The devices segment is expected to dominate the femtech market due to the rising demand for innovative health monitoring tools tailored to women's needs. Additionally, advances in wearable technology, such as fertility trackers, pregnancy monitoring devices, and menstrual health gadgets, are driving the segment's growth. Several companies and organizations are introducing advanced devices to track and monitor women's health conditions. For instance, in June 2024, Noise launched new women's health tracking features for its smart ring, Luna. This update aims to offer personalized menstrual health insights and predictions, helping women with various menstrual patterns better understand their health.

As consumers are increasingly seeking personalized, at-home healthcare solutions, the convenience and accessibility of these devices are creating more demand for these devices. Companies are collaborating to introduce advanced devices that help individuals track their health and to incorporate advanced features in the existing devices. For instance, in February 2023, Samsung Electronics and Natural Cycles entered into a partnership to bring advanced temperature-based menstrual cycle tracking capabilities to the Galaxy Watch5 series. Furthermore, continuous technological improvements in device accuracy, user experience, and integration with digital health platforms are expected to further strengthen the dominance of the devices segment in the femtech market.

Geographical Analysis

North America is expected to hold a significant position in the global femtech market share

North America holds a major portion of the femtech market and is expected to dominate the market during the forecast period. This is due to consumers' growing adoption of femtech products and services. The rising adoption and significant investment in both healthcare and technology are additional factors contributing to the region's market growth.

Companies are introducing the latest and most advanced solutions with the growing demand and supporting women's health. For instance, in December 2024, ConTIPI Medical and EVERSANA announced the U.S. commercial launch of ProVate, a new non-surgical device for women experiencing pelvic organ prolapse (POP). It is a ready-to-use, disposable device for patients' at-home use, and is now available for physicians across the U.S. to prescribe

The region's advanced healthcare infrastructure, along with a focus on women's health, supports the rapid growth of femtech innovations. Additionally, increasing R&D funding from both private and public sectors is accelerating the development of advanced solutions tailored to the needs of women, positioning North America in the dominant position.

Competitive Landscape

The major global players in the femtech market include Chiaro Technology Ltd., HeraMED, Flo Health Inc., Allara Health, Bloomlife, Syrona Health, Joylux, Inc., Coroflo Ltd., Bonzun, and Natural Cycles USA Corp among others.

Key Developments

In November 2024, PatientsLikeMe (PLM) launched Ella, an AI assistant to help women manage their health, powered by the generative AI platform Ema.
30 May 2024 - UNFPA, the United Nations Sexual and Reproductive Health Agency, launched a groundbreaking initiative to help organizations enhance their employees' reproductive health using the world's first sexual and reproductive health ESG indicators.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Femtech Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. High production costs
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Software
6.4. Services
6.5. Others

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Women's Mental Health and Well-being*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Reproductive Health
7.4. Women's Geriatric Health
7.5. Oncology
7.6. Others

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Diagnostic Centers
8.4. Fertility Centers
8.5. Cancer Centers
8.6. Home Care
8.7. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

11.1. Chiaro Technology Ltd.*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio
  - 11.1.2.1. Product Description
  - 11.1.2.2. Product Key Performance Indicators (KPIs)
  - 11.1.2.3. Historic and Forecasted Product Sales
  - 11.1.2.4. Product Sales Volume
- 11.1.3. Financial Overview
  - 11.1.3.1. Company Revenue's
  - 11.1.3.2. Geographical Revenue Shares
  - 11.1.3.3. Revenue Forecasts
- 11.1.4. Key Developments
  - 11.1.4.1. Mergers & Acquisitions
  - 11.1.4.2. Key Product Development Activities
  - 11.1.4.3. Regulatory Approvals etc.
- 11.1.5. SWOT Analysis
11.2. HeraMED
11.3. Flo Health Inc.
11.4. Allara Health
11.5. Bloomlife
11.6. Syrona Health
11.7. Joylux, Inc.
11.8. Coroflo Ltd.
11.9. Bonzun
11.10. Natural Cycles USA Corp
*Similar data will be provided for each market player.

Emerging Market Players

11.11. Athena Feminine Technologies, Inc.
- 11.11.1. Pipeline Products Description
- 11.11.2. Product Key Performance Indicators (KPIs)
- 11.11.3. Key Activities
- 11.11.4. Market Entry Timelines
- 11.11.5. Product Penetration Rate
- 11.11.6. Sales Estimation and Projections
11.12. Herbo Nutra
11.13. Orchid Lifesciences
11.14. Indo-World
11.15. Aushadhi Herbal
*Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE